课题基金 / 基金详情

Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip

Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
改善早期髋骨坏死治疗的组织工程方法
批准号:
9921203
负责人:
STUART B GOODMAN
金额:
$42.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-05 至 2023-04-30

项目摘要

项目成果

STUART B GOODMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Abstract Osteonecrosis of the femoral head (ONFH) is a potentially debilitating disease that is increasing in incidence worldwide. In the United States alone, approximately 20,000 cases of ONFH are diagnosed each year. Up to 18% of total hip replacements (THR) performed in the USA are a result of ONFH. In the early stages of ONFH, various hip joint preserving medical and surgical treatments have been tried with limited success. This is due to the fact that maintenance of the patient's own femoral head requires both mechanical and biological strategies to withstand intermittent loading and, at the same time, reconstitute the necrotic femoral head segment. Our long-term goal is to improve the treatment of ONFH using a tissue engineering approach. Our overall hypothesis is that the combination of a biomimetic functionally-graded scaffold (FGS), and preconditioned or genetically modified (GM) mesenchymal stem cells (MSCs) with anti-inflammatory, osteogenic and vascular promoting signals will provide enhanced mechanical and biological cues to reconstitute the osteonecrotic segment in ONFH. To test these hypotheses, our established team with expertise in orthopaedic surgery, biomaterials, and tissue engineering proposes the following Specific Aims: Aim 1 is to establish the efficacy of FGS for reconstitution of the femoral head in steroid-induced ONFH. Aim 2 is to establish superior efficacy of enhanced, preconditioned or GM MSCs, compared to unmodified MSCs for reconstitution of bone in the femoral head in steroid-induced ONFH. Aim 3 is to confirm that the combination of the FGS and enhanced MSCs optimizes the mechanical and biological properties in ONFH to a greater degree than either treatment or core decompression alone. This directly translational project will revolutionize and significantly improve the treatment of ONFH by introducing two novel adjunctive therapies consisting of a biomimetic resorbable load- bearing implant together with preconditioned or GM MSCs for femoral head reconstitution and preservation. 1" "
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
  • 批准号:
    10658324
  • 项目类别:
  • 资助金额:
    $77.91万
  • 财政年份:
    2023
  • 负责人:
    STUART B GOODMAN
  • 依托单位:
Customized MSCs to Enhance Healing of Bone Defects
  • 批准号:
    10115615
  • 项目类别:
  • 资助金额:
    $34.69万
  • 财政年份:
    2018
  • 负责人:
    STUART B GOODMAN
  • 依托单位:
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
  • 批准号:
    10394866
  • 项目类别:
  • 资助金额:
    $42.65万
  • 财政年份:
    2018
  • 负责人:
    STUART B GOODMAN
  • 依托单位:
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip
  • 批准号:
    9594129
  • 项目类别:
  • 资助金额:
    $45.34万
  • 财政年份:
    2018
  • 负责人:
    STUART B GOODMAN
  • 依托单位:
海外基金